ST. LOUIS, Dec. 2, 2011 PRNewswire/ -- Stereotaxis, Inc. (NASDAQ: STXS) today announced that executive management will present at the Oppenheimer Healthcare Conference to be held on December 13-14, 2011 in New York. Michael P. Kaminski, President and Chief Executive Officer of Stereotaxis, is scheduled to present an overview of the Company on Tuesday, December 13, 2011 at 10:50 a.m. ET. A live webcast and subsequent archived replay of the presentation will be accessible at http://www.stereotaxis.com/event_calendar.html. The replay will be available for 90 days after the event. About Stereotaxis www.stereotaxis.comwww.odysseyexperience.com Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Niobe ® Remote Magnetic Navigation System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation and reduced x-ray exposure. Stereotaxis' Odyssey™ portfolio of products provides an innovative enterprise solution for integrating, recording and networking interventional lab information within hospitals and around the world. Odyssey™ Vision integrates data for magnetic and standard interventional labs, enhancing the physician workflow through a consolidated display of multiple systems and eliminating the challenge of interacting simultaneously with many separate diagnostic systems. The Odyssey Cinema™ Studio then captures a complete record of synchronized procedure data that can be viewed live or from a comprehensive archive of cases performed. Odyssey™ solution then enables hospitals to efficiently share live and recorded clinical data anywhere around the world to attract patients and promote collaboration.